全文获取类型
收费全文 | 2459篇 |
免费 | 127篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 149篇 |
妇产科学 | 75篇 |
基础医学 | 380篇 |
口腔科学 | 55篇 |
临床医学 | 266篇 |
内科学 | 520篇 |
皮肤病学 | 43篇 |
神经病学 | 108篇 |
特种医学 | 276篇 |
外科学 | 255篇 |
综合类 | 23篇 |
预防医学 | 96篇 |
眼科学 | 32篇 |
药学 | 134篇 |
中国医学 | 1篇 |
肿瘤学 | 152篇 |
出版年
2023年 | 15篇 |
2022年 | 21篇 |
2021年 | 52篇 |
2020年 | 15篇 |
2019年 | 32篇 |
2018年 | 37篇 |
2017年 | 33篇 |
2016年 | 26篇 |
2015年 | 38篇 |
2014年 | 44篇 |
2013年 | 48篇 |
2012年 | 95篇 |
2011年 | 77篇 |
2010年 | 97篇 |
2009年 | 81篇 |
2008年 | 110篇 |
2007年 | 102篇 |
2006年 | 114篇 |
2005年 | 110篇 |
2004年 | 99篇 |
2003年 | 78篇 |
2002年 | 59篇 |
2001年 | 45篇 |
2000年 | 29篇 |
1999年 | 33篇 |
1998年 | 63篇 |
1997年 | 74篇 |
1996年 | 59篇 |
1995年 | 49篇 |
1994年 | 56篇 |
1993年 | 59篇 |
1992年 | 29篇 |
1991年 | 25篇 |
1990年 | 26篇 |
1989年 | 48篇 |
1988年 | 56篇 |
1987年 | 43篇 |
1986年 | 41篇 |
1985年 | 42篇 |
1984年 | 28篇 |
1983年 | 40篇 |
1982年 | 24篇 |
1981年 | 27篇 |
1980年 | 27篇 |
1978年 | 21篇 |
1977年 | 19篇 |
1976年 | 18篇 |
1975年 | 23篇 |
1932年 | 11篇 |
1929年 | 18篇 |
排序方式: 共有2589条查询结果,搜索用时 31 毫秒
91.
Idit Tessler Meir Warman Itai Amos Doron Halperin Yosef Bavnik Asher Milstein Yochai Shoshani Hana Leiba Oded Cohen 《Auris, nasus, larynx》2021,48(5):898-904
ObjectiveDespite increased risks of nasolacrimal duct obstruction (NLDO) with age, and the continuous growth of the old population proportion, data on endoscopic dacryocystorhinostomy (eDCR) among the old is lacking. This study aims to evaluate long-term eDCR efficacy and safety in the old and oldest-old population.MethodsA retrospective case-control study of patients aged 80 ≤ (oldest-old) and 65–79 (old) compared with younger controls who underwent eDCR, between 2002 and 2017. Pre-, intra- and postoperative factors were collected using an integrated hospital-community system. Success rates were analyzed and measured at the first visit following surgery (immediate success), and after five years. Demographics, comorbidities, complications rates, and outcomes were compared between the groups.ResultsThe study groups included 52 oldest-old patients (mean age 83.4 ± 3.6), 127 old patients (72.3 ± 4.14) and 142 control patients (57.8 ± 18.0). The immediate and success rates were 94.2%, 93.7% and 90.8% and five-year success rates were 80.0%, 76.6% and 80% among oldest-old, old and controls, respectively. No significant differences in success rates were found, even despite higher comorbidity rates among the study's group (96 and 92.8% vs. 63.2%, among oldest-old, old and controls respectively, p <0.001). Intra- and postoperative complications rates were low in all groups.ConclusionsAmong older population, including oldest-old and old, eDCR safety and long-term outcomes are comparable with younger patients, suggesting that eDCR should be offered to NLDO patients, regardless of age. 相似文献
92.
93.
幽门螺杆菌cagⅡ对胃上皮细胞IL-8基因转录的影响及机制 总被引:6,自引:0,他引:6
目的探讨HpcagⅡ对胃上皮细胞IL-8基因转录的影响及信号传导机制。方法构建
cagⅡ基因位点缺失Hp突变株及带有IL-8报告基因的人胃癌细胞系L5F11,用液体闪烁计数仪测定荧光素酶(IL8转录)活性,用ELISA法测定IL8蛋白浓度。结果所有Hp突变株诱导荧光素酶活性与IL8蛋白浓度较亲代菌株26695均降低[(0.13±0.01)×cpm比(0.59±0.05)×(P<0.01);(0.73±0.13)ng/ml比(2.22±0.65)ng/ml,(P<0.05)]。PTK抑制剂herbimycinA不仅抑制Hp诱导的荧光素酶活性[(0.71±0.18)×cpm比(1.51±0.23)×cpm,(P<0.05)],而且抑制IL-8蛋白表达[(0.83±0.41)ng/ml比(3.22±0.59)ng/ml,(P<0.05)],但herbimycinA对TNFα诱导的荧光素酶活性及IL8蛋白表达均无影响(P均>0.05);PKA抑制剂H7抑制TNFα诱导的荧光素酶活性[(0.74±0.16)×cpm比(2.62±0.26)×cpm,(P<0.001)]及IL8蛋白表达[(1.45±0.38)ng/ml比(4.12±0.43)ng/ml,(P<0.01)],而对Hp诱导的荧光素酶活性无影响(P>0.05)。结论HpcagⅡ中的多基因能够调节胃上皮细胞IL-8基因转录,且这一作用主要经蛋白酪氨酸激酶途径。 相似文献
94.
95.
Attention deficit/hyperactivity disorder (ADHD) is a neurobehavioral condition found in 5-10% of school-age children and in 2-5% of adults. Stimulants affecting the dopaminergic, noradrenergic and/or serotonergic systems are commonly used for treatment in children and adults, including women of childbearing age. The data on the effects of stimulants (methylphenidate and amphetamines) in pregnancy are generally reassuring, but methylphenidate might slightly increase the rate of cardiac malformations and of spontaneous abortions, while amphetamines might slightly increase the risk for premature birth, low birth weight and other pregnancy complications. Bupropion, a dopamine and norepinephrine reuptake inhibitor, when used as an antidepressant, appears to be safe in pregnancy. The data on the use of atomoxetine, guanfacine and clonidine in pregnancy are scarce. Importantly, there are practically no data on the long-term neurodevelopmental effects of most of these drugs. The published data on the development of children born to methamphetamine-abusing women may be misleading since these women generally use other drugs, including alcohol, and the home environment where the child is raised may not be optimal. The treating physician should judge the need for treatment during pregnancy in relation to the severity of the clinical symptoms. If needed, methylphenidate is preferred over amphetamines because breast feeding is possible. If one uses non-stimulant medications, bupropion seems to be the preferred drug. 相似文献
96.
97.
Beigel R Hod H Fefer P Asher E Novikov I Shenkman B Savion N Varon D Matetzky S 《The American journal of cardiology》2011,(3):339-342
Aspirin failure, defined as occurrence of an acute coronary syndrome despite aspirin use, has been associated with a higher cardiovascular risk profile and worse prognosis. Whether this phenomenon is a manifestation of patient characteristics or failure of adequate platelet inhibition by aspirin has never been studied. We evaluated 174 consecutive patients with acute myocardial infarction. Of them, 118 (68%) were aspirin naive and 56 (32%) were regarded as having aspirin failure. Platelet function was analyzed after ≥72 hours of aspirin therapy in all patients. Platelet reactivity was studied by light-transmitted aggregometry and under flow conditions. Six-month incidence of major adverse coronary events (death, recurrent acute coronary syndrome, and/or stroke) was determined. Those with aspirin failure were older (p = 0.002), more hypertensive (p <0.001), more hyperlipidemic (p <0.001), and more likely to have had a previous cardiovascular event and/or procedure (p <0.001). Cumulative 6-month major adverse coronary events were higher in the aspirin-failure group (14.3% vs 2.5% p <0.01). Patients with aspirin failure had lower arachidonic acid-induced platelet aggregation (32 ± 24 vs 45 ± 30, p = 0.003) after aspirin therapy compared to their aspirin-naive counterparts. However, this was not significant after adjusting for differences in baseline characteristics (p = 0.82). Similarly, there were no significant differences in adenosine diphosphate-induced platelet aggregation and platelet deposition under flow conditions. In conclusion, our results suggest that aspirin failure is merely a marker of higher-risk patient profiles and not a manifestation of inadequate platelet response to aspirin therapy. 相似文献
98.
Jing Ping Sun Edward Chinchoy Erwan Donal Zoran B Popovi? George Perlic Craig R Asher Neil L Greenberg Richard A Grimm Bruce L Wilkoff James D Thomas 《Journal of the American Society of Echocardiography》2004,17(8):845-850
Cardiac resynchronization therapy improves hemodynamics in selected patients with heart failure. Mechanic asynchrony parameters that may guide patient selection or therapy optimization are still being investigated. A biventricular (BiV) pacemaker was implanted in 34 patients with dilated ischemic, idiopathic, or valvular cardiomyopathy, and a QRS duration of > or =130 milliseconds. Two-dimensional standard and Doppler tissue echocardiography was performed during right ventricular (RV), left ventricular (LV), BiV, and no pacing in a random and blinded manner. LV and BiV pacing increased stroke volume (P <.02 for both) and ejection fraction (P <.001 for both). Regional contractility assessed by displacement, strain rate, and peak systolic strain was improved in some segments (P <.05) during LV and BiV pacing. A homogenization of segmental contractions was observed during LV and BiV pacing as evaluated by net systolic displacement and segmental myocardial performance index. LV and BiV pacing provides benefits that can be quantified by echocardiography. 相似文献
99.
Bar-Oz B Diav-Citrin O Shechtman S Tellem R Arnon J Francetic I Berkovitch M Ornoy A 《European journal of obstetrics, gynecology, and reproductive biology》2008,141(1):31-34
Objectives
To determine whether the use of the new macrolides (azithromycin, clarithromycin, roxithromycin) during the first trimester of pregnancy is associated with an increased risk of major malformations.Study design
In a prospective multi-center study, pregnancy outcome was compared between pregnant women exposed to one of the new macrolides during the first trimester of pregnancy and two comparison groups one exposed to other antibiotics and the other to other non-teratogenic medications. All women enrolled in the study called one of the three participating teratogen information services (TIS). Group 1 macrolides (n = 161), group 2 other antibiotics (n = 213) and group 3 non-teratogens (n = 740).Results
A total of 161 women exposed to the new macrolides (118 were exposed in the first trimester of pregnancy) and 953 from a comparison groups were followed up. The rate of major malformations in the study group was 4.1% compared to 2.1% in the other antibiotics exposed group (OR = 1.41, 95% CI 0.47–4.23) and 3.0% in the non-teratogens exposed group. The rate of elective terminations of pregnancy was significantly higher in the exposed group in compare to both comparison groups.Conclusion
Our study, although relatively small sized, suggests that the use of the new macrolides during the first trimester of pregnancy does not represent an increased risk for congenital malformations strong enough for an induced abortion after such an exposure. Elective terminations of pregnancy because of early exposure to these medications should be reconsidered. 相似文献100.
Bethe Rona Leon Asher Peausnitz W. Teschendorf Harms Noeggerath Konjetzny W. Knothe Melchior 《Journal of molecular medicine (Berlin, Germany)》1932,11(40):1684-1685
Ohne Zusammenfassung 相似文献